Key Takeaways
- CRWV shares plunged over 11% following a first-quarter earnings report that disappointed investors
- The company posted a per-share loss of -$1.40, significantly worse than the consensus estimate of -$0.92
- Top-line results exceeded expectations with revenue of $2.08 billion, representing 127% year-over-year growth
- Major stakeholder Magnetar Financial liquidated $370.5 million in CRWV shares immediately following the earnings announcement
- Aggregate insider dispositions over the previous three months have reached approximately $1.9 billion, earning a “Negative” insider sentiment designation
Shares of CoreWeave experienced a sharp decline exceeding 11% during extended trading hours on May 8, following the release of first-quarter 2026 financial results that disappointed on profitability metrics.
CoreWeave, Inc. Class A Common Stock, CRWV
Following the post-market decline, CRWV traded near the $114 level, representing a significant retreat from the $129-plus prices observed earlier in the trading week.
The AI infrastructure provider disclosed a quarterly loss of $1.40 per share for the first quarter of 2026. Analyst consensus had projected a smaller loss of $0.92 per share. The substantial deviation raised immediate concerns among market participants.
Management provided conservative forward guidance for the remainder of fiscal 2026, citing escalating infrastructure expenditures and intensifying competitive pressures within the artificial intelligence cloud computing sector.
On the revenue front, however, the picture looked considerably brighter. CoreWeave generated $2.08 billion in quarterly revenue, marking a robust 127% increase compared to the year-ago period. This figure surpassed Wall Street’s projection of $1.97 billion.
The firm additionally reported expansion in its revenue backlog and highlighted that its total active power capacity surpassed the one-gigawatt threshold during the reporting period.
DA Davidson maintained its optimistic stance on the stock following the quarterly release, reaffirming its Buy recommendation with a $175 price objective. The brokerage firm stood by its bullish outlook despite the bottom-line shortfall.
Major Stakeholder Dumps $370 Million on Earnings Day
As market participants processed the weaker-than-expected earnings results, CoreWeave’s principal insider was actively reducing its position.
Magnetar Financial LLC, controlling more than 10% of CoreWeave‘s outstanding shares, completed four distinct sale transactions on May 8—the identical day the company released its quarterly report.
The investment firm disposed of more than 2.7 million shares at execution prices ranging from $129 to $139, generating aggregate proceeds of $370.45 million.
An additional regulatory filing disclosed that Magnetar-affiliated entities had also sold 157,368 shares one day earlier on May 7, at prices spanning $129.73 to $133.00, producing approximately $20.7 million in total proceeds.
These transactions were carried out across multiple Magnetar Funds, with Magnetar Financial LLC acting in its capacity as investment adviser.
Three-Month Insider Selling Reaches $1.9 Billion
The substantial May 8 disposition represents merely the latest chapter in an extended pattern of selling activity. Throughout the preceding three-month window, company insiders collectively divested approximately $1.9 billion worth of CRWV equity.
This extraordinary selling volume has resulted in CoreWeave receiving a “Negative” insider activity classification according to TipRanks metrics.
While corporate insiders may liquidate holdings for various legitimate reasons unrelated to company fundamentals, the sheer magnitude of recent selling activity has captured investor attention, particularly given the stock’s impressive recent performance trajectory.
Prior to the earnings-related decline, CRWV had appreciated 59% during the current calendar year and had posted approximately 95% gains over the trailing twelve-month period.
According to InvestingPro analysis, CoreWeave’s current market valuation exceeds its calculated Fair Value, suggesting the shares may be trading above fundamental support levels.
Wall Street maintains a Moderate Buy consensus stance on CRWV, derived from 14 Buy recommendations, nine Hold ratings, and one Sell opinion. The mean analyst price target stands at $133.70, suggesting potential appreciation of approximately 17% from present trading levels.
The most recent analyst commentary originated from DA Davidson, which reaffirmed its Buy rating alongside a $175 price objective in response to the first-quarter financial disclosure.


